000 | 01932 a2200577 4500 | ||
---|---|---|---|
005 | 20250517070227.0 | ||
264 | 0 | _c20160623 | |
008 | 201606s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0144355 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTakaoka, Kazuki | |
245 | 0 | 0 |
_aEstablishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats. _h[electronic resource] |
260 |
_bPloS one _c2015 |
||
300 |
_ae0144355 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcid Phosphatase _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xcomplications |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aBone Remodeling |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xadverse effects |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aIsoenzymes _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaxilla _xmetabolism |
650 | 0 | 4 |
_aMolar _xmetabolism |
650 | 0 | 4 |
_aOsteoclasts _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRats, Transgenic |
650 | 0 | 4 | _aTartrate-Resistant Acid Phosphatase |
650 | 0 | 4 | _aTooth Extraction |
650 | 0 | 4 | _aZoledronic Acid |
700 | 1 | _aYamamura, Michiyo | |
700 | 1 | _aNishioka, Toshihiro | |
700 | 1 | _aAbe, Tetsuya | |
700 | 1 | _aTamaoka, Joji | |
700 | 1 | _aSegawa, Emi | |
700 | 1 | _aShinohara, Masami | |
700 | 1 | _aUeda, Haruyasu | |
700 | 1 | _aKishimoto, Hiromitsu | |
700 | 1 | _aUrade, Masahiro | |
773 | 0 |
_tPloS one _gvol. 10 _gno. 12 _gp. e0144355 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0144355 _zAvailable from publisher's website |
999 |
_c25534372 _d25534372 |